Microbiological characteristics, risk factors and mortality in children with bloodstream infection of carbapenem resistance Enterobacteriaceae: a 10-year longitudinal study

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Carbapenem-resistant Enterobacteriaceae (CRE) is rapidly becoming a major threat to hospitalized children worldwide. The purpose of this study was to summarize etiological characteristics and identify risk factors relevant to CRE bloodstream infection and short-term mortality among pediatric patients in China. Methods: In this study, we included 370 inpatients ≤ 17 years old with BSI caused by CRE in China from January 2013 to December 2022. By collecting data on demographics, etiological features, and clinical outcomes, we conducted an in-depth analysis. Result: Among the 370 BSI patients, there were 35 patients (9.46 %) caused by CRE and 335 patients (90.54 %) by carbapenem-susceptible Enterobacteriaceae (CSE). Among these CRE strains, Klebsiella pneumoniae was the most important pathogen of BSI in pediatric patients, followed by Escherichia coli and Enterobacter cloacae . The most frequent carbapenemase was NDM (23/35, 65.71%), followed by KPC (8/35, 22.86%). The overall 28-day mortality rate of children with an Enterobacteriaceae BSI episode was 1.89 % (7/370 ), of which CRE BSI patients (3/ 35, 8.57 %) were significantly higher than CSE patients (4 / 335, 1.19 %, P < 0.001). Congenital malformation (OR:8.162, 95% CI: 3.859 - 16.680, P<0.001), CRP >10 mg/mL (OR:18.870, 95%CI 6.154 - 59.400, P: <0.0001) and catheter-related (OR: 6.645, 95% CI: 3.159 - 13.28, P: <0.0001) were found to be associated with the development of CRE BSI in pediatric patients. A multivariate analysis showed that the colonization and infection of CRE (OR 7.758, 95% CI 1.869-29.62, P = 0.021) were independent risk factors for 28-day mortality of Enterobacteriaceae BSI. When the MIC of carbapenems is ≥ 8 μg/mL, the admission rate and mortality rate in the ICU were higher(P<0.05). Conclusions: Congenital malformation, previous cephalosporin/carbapenems administration, and catheter-related conditions are closely related to the development of CRE BSI in pediatric patients. The mortality rate of CRE BSI is higher. NDM was the predominant carbapenemase-producing mechanism among CRE strains causing BSI in children.

Article activity feed